Britain's Competition and Markets Authority slapped pharmaceutical company Pfizer with a fine equivalent to about $107 million for hiking the price of phenytoin sodium capsules. The epilepsy drug is used by about 48,000 patients in the UK.
Pfizer Fined $107M for 2,600 Percent Price Hike On Epilepsy Drug Phenytoin Sodium
Tech Times - 8 Dec 2016 08:43
Britain's Competition and Markets Authority slapped pharmaceutical company Pfizer with a fine equivalent to about $107 million for hiking the price of phenytoin sodium capsules. The epilepsy drug is used by about 48,000 patients in the UK.
Share this Article
Recommended